Mylan agreed to pay $465 million to settle federal government claims that it overcharged the Medicaid program by millions of dollars for its EpiPen products.
WSJ.com: Asia Home, Wall Street Journal: Home Asia
Thu, 08/17/2017 - 1:49pm
Mylan agreed to pay $465 million to settle federal government claims that it overcharged the Medicaid program by millions of dollars for its EpiPen products.